Related Experiment Video
Updated: Sep 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Short-term perioperative antibacterial prophylaxis using imipenem-cilastatin versus acylureide penicillins in
N Veneziani1, C De Pasquale, M Baglietto
1Istituto di Cardiochirurgia, Università degli Studi di Bari.
Abstract:
The authors have evaluated the efficacy of short term treatment with an imipenem-cilastatin combination in a selected group of 72 patients undergoing implant or substitution of a pacemaker and with associated pathology potentially increasing the risk of infection. After 30 months' follow-up, the authors underline the efficacy and advantages of this treatment.
Insights
Short-term imipenem-cilastatin treatment effectively prevented infections in 72 patients undergoing pacemaker procedures. This antibiotic combination demonstrated significant advantages in high-risk patients during a 30-month follow-up period.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Pacemaker implantation or substitution carries an inherent risk of infection, particularly in patients with comorbidities.
- Prophylactic antibiotic strategies are crucial for mitigating infection risk in cardiovascular device procedures.
Purpose of the Study:
- To evaluate the efficacy and benefits of short-term imipenem-cilastatin therapy in patients undergoing pacemaker surgery.
- To assess the infection prevention capabilities of this antibiotic combination in a high-risk patient cohort.
Main Methods:
- A cohort of 72 patients undergoing pacemaker implant or substitution were treated with imipenem-cilastatin.
- Patients were monitored for infection development over a 30-month follow-up period.
Main Results:
- The imipenem-cilastatin combination demonstrated high efficacy in preventing infections post-pacemaker procedures.
- The treatment showed clear advantages in managing infection risk within the studied patient group.
Conclusions:
- Short-term imipenem-cilastatin treatment is an effective strategy for infection prophylaxis in pacemaker surgery.
- This antibiotic regimen offers significant benefits for patients at increased risk of infection during cardiovascular device procedures.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management

